These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 9445186

  • 1. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B, Lee JS, Palmer J, Fossella F, Shin DM, Murphy WK, Perez-Soler R, Hong WK.
    Cancer; 1998 Jan 15; 82(2):301-8. PubMed ID: 9445186
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.
    Glisson BS, Kurie JM, Perez-Soler R, Fox NJ, Murphy WK, Fossella FV, Lee JS, Ross MB, Nyberg DA, Pisters KM, Shin DM, Hong WK.
    J Clin Oncol; 1999 Aug 15; 17(8):2309-15. PubMed ID: 10561292
    [Abstract] [Full Text] [Related]

  • 3. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA, Evans WK, Goss PE, Latreille J, Logan D, Maroun J, Stewart D, Warner E, Paul K.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV, Frytak S, Rubin J, Camoriano JK, Fitch TR.
    Am J Clin Oncol; 1997 Oct 15; 20(5):500-4. PubMed ID: 9345336
    [Abstract] [Full Text] [Related]

  • 5. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov 15; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY, Boros L, Garrow GC, Asbury RF, Hui L.
    Semin Oncol; 1996 Jun 15; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [Abstract] [Full Text] [Related]

  • 7. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S.
    Semin Oncol; 1992 Dec 15; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [Abstract] [Full Text] [Related]

  • 8. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 9. Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
    Glisson B, Komaki R, Lee JS, Shin DM, Fossella F, Murphy WK, Kurie J, Perez-Soler R, Schea R, Vadhan-Raj S.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):331-6. PubMed ID: 9457817
    [Abstract] [Full Text] [Related]

  • 10. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
    Dodd PM, McCaffrey JA, Hilton S, Mazumdar M, Herr H, Kelly WK, Icasiano E, Boyle MG, Bajorin DF.
    J Clin Oncol; 2000 Feb 15; 18(4):840-6. PubMed ID: 10673526
    [Abstract] [Full Text] [Related]

  • 11. A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
    Mavroudis D, Papadakis E, Veslemes M, Tsiafaki X, Stavrakakis J, Kouroussis C, Kakolyris S, Bania E, Jordanoglou J, Agelidou M, Vlachonicolis J, Georgoulias V, Greek Lung Cancer Cooperative Group.
    Ann Oncol; 2001 Apr 15; 12(4):463-70. PubMed ID: 11398877
    [Abstract] [Full Text] [Related]

  • 12. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.
    Ann Oncol; 1997 Jan 15; 8(1):49-56. PubMed ID: 9093707
    [Abstract] [Full Text] [Related]

  • 13. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
    Miller AA, Herndon JE, Hollis DR, Ellerton J, Langleben A, Richards F, Green MR.
    J Clin Oncol; 1995 Aug 15; 13(8):1871-9. PubMed ID: 7636529
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
    Glisson B, Scott C, Komaki R, Movsas B, Wagner H.
    J Clin Oncol; 2000 Aug 15; 18(16):2990-5. PubMed ID: 10944132
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA, Kelly K.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):11-5. PubMed ID: 9007114
    [Abstract] [Full Text] [Related]

  • 16. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
    Hanauske AR, Korfel A, Perker M, Heinrich B, Schwab G, Graf M, Depenbrock H, Höffken G, Kreuser ED, Thiel E, Zwingers T, Berdel WE.
    Oncology; 1997 Dec 15; 54(5):363-70. PubMed ID: 9260596
    [Abstract] [Full Text] [Related]

  • 17. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
    Graziano SL, Herndon JE, Richards F, DiFino S, Modeas C, Duggan DB, Green MR.
    Cancer; 1993 Jul 01; 72(1):62-8. PubMed ID: 8389667
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S.
    J Clin Oncol; 1987 Dec 01; 5(12):1880-9. PubMed ID: 2824710
    [Abstract] [Full Text] [Related]

  • 19. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS.
    Semin Oncol; 1996 Jun 01; 23(3 Suppl 6):78-83. PubMed ID: 8677455
    [Abstract] [Full Text] [Related]

  • 20. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL, Valone FH, Herndon JE, Crawford J, Richards F, Rege VB, Clamon G, Green MR.
    Lung Cancer; 1996 Jun 01; 14(2-3):315-29. PubMed ID: 8794413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.